본문으로 건너뛰기
← 뒤로

Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.

1/5 보강
British journal of cancer 2026 Vol.134(6) p. 849-859
Retraction 확인
출처

PICO 자동 추출 (휴리스틱, conf 2/4)

유사 논문
P · Population 대상 환자/모집단
591 patients with resected PDAC to train an AI model for recurrence prediction at 12 or 24 months and validated it using external cohorts (n = 302 in total).
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
High-risk clusters showed elevated CSF3R expression; the low-risk cluster showed increased IGFBP3 expression. [CONCLUSIONS] Our AI model, using only archival histologic slides, accurately predicted postoperative recurrence in PDAC and revealed image features linked to outcomes and gene expression.

Takamatsu M, Tanaka M, Masugi Y, Inoue Y, Nagano H, Le TN, Nishida K, Sawa Y, Sugiura K, Kawaguchi Y, Kazami Y, Nakai Y, Hamada T, Suzuki T, Hara K, Kurebayashi Y, Takeda T, Sasahira N, Uematsu Y, Uemura S, Fujishiro M, Hasegawa K, Kitago M, Takahashi Y, Sekine S, Ushiku T, Takeuchi K

📝 환자 설명용 한 줄

[BACKGROUND] Prognostication for pancreatic ductal adenocarcinoma (PDAC) using histologic images is difficult due to tumor heterogeneity.

🔬 핵심 임상 통계 (초록에서 자동 추출 — 원문 검증 권장)
  • 표본수 (n) 302
  • p-value P < 0.01

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Takamatsu M, Tanaka M, et al. (2026). Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.. British journal of cancer, 134(6), 849-859. https://doi.org/10.1038/s41416-025-03308-7
MLA Takamatsu M, et al.. "Prognostic model for pancreatic cancer based on machine learning of routine slides and transcriptomic tumor analysis.." British journal of cancer, vol. 134, no. 6, 2026, pp. 849-859.
PMID 41507565

Abstract

[BACKGROUND] Prognostication for pancreatic ductal adenocarcinoma (PDAC) using histologic images is difficult due to tumor heterogeneity. We developed an artificial intelligence (AI) model to predict postoperative recurrence using histologic image patches.

[METHODS] We included 591 patients with resected PDAC to train an AI model for recurrence prediction at 12 or 24 months and validated it using external cohorts (n = 302 in total). Image patches from hematoxylin and eosin-stained slides were clustered via uniform manifold approximation and projection (UMAP) and used to train a random forest model. Predictive performance was evaluated using area under the receiver operating characteristic curve (AUC). Gene expression analysis was conducted to characterise survival-related clusters.

[RESULTS] Seventeen patch clusters were identified. Two were linked to high recurrence risk, and one to low risk. In external validation, the model achieved an AUC of up to 0.792. The random forest score independently predicted recurrence. Greater heterogeneity in patch composition correlated with shorter time to recurrence (P < 0.01). High-risk clusters showed elevated CSF3R expression; the low-risk cluster showed increased IGFBP3 expression.

[CONCLUSIONS] Our AI model, using only archival histologic slides, accurately predicted postoperative recurrence in PDAC and revealed image features linked to outcomes and gene expression.

MeSH Terms

Humans; Pancreatic Neoplasms; Prognosis; Machine Learning; Female; Male; Carcinoma, Pancreatic Ductal; Middle Aged; Aged; Neoplasm Recurrence, Local; Gene Expression Profiling; Transcriptome; Biomarkers, Tumor